AP NEWS

Ra Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference

September 25, 2018

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep 25, 2018--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Doug Treco, PhD, President and Chief Executive Officer of Ra Pharma, will present at the 2018 Cantor Global Healthcare Conference on Tuesday, October 2, 2018 at 9:10 a.m. E.T. The conference is being held at the InterContinental New York Barclay Hotel.

The presentation will be webcast live and can be accessed by visiting the investor relations section of the Company’s website,  www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit:  www.rapharma.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180925005948/en/

CONTACT: Investors:

Argot Partners

Natalie Wildenradt, 212-600-1902

natalie@argotpartners.com

or

Media:

Argot Partners

David Rosen, 212-600-1902

david.rosen@argotpartners.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES BANKING FINANCE

SOURCE: Ra Pharmaceuticals, Inc.

Copyright Business Wire 2018.

PUB: 09/25/2018 04:05 PM/DISC: 09/25/2018 04:05 PM

http://www.businesswire.com/news/home/20180925005948/en

AP RADIO
Update hourly